Shares of Thermo Fisher Scientific Inc. TMO slid 1.13% to $540.75 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 0.29% to ...
Thermo Fisher Scientific has signed an agreement with German molecular genetics company Mainz Biomed, the developer of ...
Mainz Biomed B.V. (MYNZ) has released an update. Mainz Biomed has announced a collaboration with Thermo Fisher Scientific to develop a next-generation colorectal cancer screening test. This ...
Mainz Biomed (MYNZ) announced a collaborative agreement with Thermo Fisher Scientific (TMO), through its subsidiary Life Technologies. The collaboration agreement will enable Mainz Biomed and Thermo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback